돼지 백신 시장 규모, 점유율, 성장 분석 : 백신 유형별, 질병 유형별, 투여 경로별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Swine Vaccines Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.21 Billion in 2025 to USD 3.31 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global swine vaccines market is experiencing significant growth driven by the urgent need to combat disease outbreaks that threaten economic stability and food security. This market encompasses a range of offerings, including commercial and autogenous vaccines, integrated delivery technologies, diagnostics-linked immunization programs, and services tailored for pork producers and veterinarians. Enhanced herd resilience is crucial for sustaining trade, safeguarding jobs, and ensuring public health. Innovative technologies, such as recombinant and vectored vaccine platforms, are being leveraged to improve safety while facilitating DIVA testing to enhance export opportunities and mitigate costs. Additionally, AI is revolutionizing vaccine development by accelerating antigen discovery and optimizing formulations, enabling more efficient responses to outbreaks while reducing research expenditure, thus attracting global animal health firms and expanding market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Swine Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Swine Vaccines Market Segments Analysis

Global swine vaccines market is segmented by by vaccine type, by disease type, by route of administration, by application, by end user, by distribution channel and region. Based on by vaccine type, the market is segmented into Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines and Others. Based on by disease type, the market is segmented into Porcine Reproductive & Respiratory Syndrome, Swine Influenza, Porcine Circovirus Associated Disease, Classical Swine Fever, Mycoplasma Hyopneumoniae, Foot-and-mouth Disease and Others. Based on by route of administration, the market is segmented into Injectable Vaccines, Oral Vaccines and Intranasal Vaccines. Based on by application, the market is segmented into Disease Prevention, Disease Control and Herd Health Management. Based on by end user, the market is segmented into Veterinary Hospitals & Clinics, Swine Farms, Research Institutes, Government Veterinary Agencies and Others. Based on by distribution channel, the market is segmented into Veterinary Pharmacies, Direct Sales and Online Veterinary Platforms. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Swine Vaccines Market

The increasing prevalence of swine infectious diseases has led producers to recognize the critical importance of preventive measures, resulting in a broader adoption of vaccine programs as fundamental elements of herd health management. As the industry emphasizes the need to minimize losses and enhance productivity, there is a greater commitment to vaccination schedules and ancillary services, prompting manufacturers to expand their product offerings and refine distribution networks. This alignment among producer objectives, veterinary recommendations, and supply chain capabilities fosters a heightened demand for prophylactic vaccination, establishing it as a key risk management strategy across diverse global production systems.

Restraints in the Global Swine Vaccines Market

The Global Swine Vaccines market faces significant challenges due to the intricate and lengthy process of developing, validating, and obtaining regulatory approval for new vaccines. This complexity acts as a substantial barrier for companies aiming to introduce innovative products, as they must demonstrate consistent safety and efficacy in varying production conditions, leading to increased costs and prolonged timelines. Smaller companies, in particular, may feel discouraged, resulting in slower portfolio growth. Additionally, regulatory uncertainty and differing expectations across jurisdictions complicate the commercialization process, thereby restricting the pace and extent of adoption for new scientific advancements, ultimately hampering overall market expansion.

Market Trends of the Global Swine Vaccines Market

The Global Swine Vaccines market is experiencing a significant shift toward precision vaccinology, driven by advances in molecular design and targeted antigen development. This innovative approach allows for the creation of vaccines tailored to specific swine pathogens and production environments, enhancing protective responses while minimizing unintended effects. Integration of genomic surveillance into the vaccine development process ensures alignment with circulating pathogens, facilitating adaptation to local epidemiological trends. Additionally, new delivery platforms promote safer administration and prolong immunity duration. This evolution supports more targeted immunization strategies, bolsters herd resilience, reduces reliance on broad-spectrum treatments, and fosters sustainable herd health management practices among veterinary partners and producers.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Swine Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Subunit Vaccines
• Others

Global Swine Vaccines Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Porcine Reproductive & Respiratory Syndrome
• Swine Influenza
• Porcine Circovirus Associated Disease
• Classical Swine Fever
• Mycoplasma Hyopneumoniae
• Foot-and-mouth Disease
• Others

Global Swine Vaccines Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectable Vaccines
• Oral Vaccines
• Intranasal Vaccines

Global Swine Vaccines Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Prevention
• Disease Control
• Herd Health Management

Global Swine Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Swine Farms
• Research Institutes
• Government Veterinary Agencies
• Others

Global Swine Vaccines Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Pharmacies
• Direct Sales
• Online Veterinary Platforms

Global Swine Vaccines Market Size & CAGR (2026-2033)

• North America (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • US
  • Canada
• Europe (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Vaccine Type, By Disease Type, By Route of Administration, By Application, By End User, By Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KM Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratorios Calier
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDT Biologika
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrovet Market
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinyu Bio-technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FATRO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations